CN101411893A - Titanium or titanium alloy material with modified surface as well as preparation method and use thereof - Google Patents
Titanium or titanium alloy material with modified surface as well as preparation method and use thereof Download PDFInfo
- Publication number
- CN101411893A CN101411893A CNA2008102330814A CN200810233081A CN101411893A CN 101411893 A CN101411893 A CN 101411893A CN A2008102330814 A CNA2008102330814 A CN A2008102330814A CN 200810233081 A CN200810233081 A CN 200810233081A CN 101411893 A CN101411893 A CN 101411893A
- Authority
- CN
- China
- Prior art keywords
- titanium
- alloy material
- titanium alloy
- chitosan
- surface modification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910001069 Ti alloy Inorganic materials 0.000 title claims abstract description 66
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 title claims abstract description 66
- 239000010936 titanium Substances 0.000 title claims abstract description 64
- 239000000956 alloy Substances 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 63
- 108010022355 Fibroins Proteins 0.000 claims abstract description 38
- 229920001661 Chitosan Polymers 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 17
- 238000000576 coating method Methods 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 15
- 239000011248 coating agent Substances 0.000 claims abstract description 11
- 238000001338 self-assembly Methods 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 39
- 239000008367 deionised water Substances 0.000 claims description 26
- 229910021641 deionized water Inorganic materials 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 16
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 16
- 230000004048 modification Effects 0.000 claims description 16
- 238000012986 modification Methods 0.000 claims description 16
- 239000011259 mixed solution Substances 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 9
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000012460 protein solution Substances 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- 150000003608 titanium Chemical class 0.000 abstract description 29
- 239000007943 implant Substances 0.000 abstract description 8
- 230000000975 bioactive effect Effects 0.000 abstract description 7
- 239000003792 electrolyte Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000001179 sorption measurement Methods 0.000 abstract description 3
- 229920000447 polyanionic polymer Polymers 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 2
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 210000000963 osteoblast Anatomy 0.000 description 13
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 12
- 238000002791 soaking Methods 0.000 description 10
- 239000012528 membrane Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 230000004071 biological effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000003760 magnetic stirring Methods 0.000 description 4
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 229910000883 Ti6Al4V Inorganic materials 0.000 description 3
- 238000002715 modification method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- MBDICAOEPMIKPN-UHFFFAOYSA-L calcium ethanol dichloride hydrate Chemical compound O.C(C)O.[Cl-].[Ca+2].[Cl-] MBDICAOEPMIKPN-UHFFFAOYSA-L 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005566 electron beam evaporation Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 238000010883 osseointegration Methods 0.000 description 1
- 230000004072 osteoblast differentiation Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000007750 plasma spraying Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 230000027849 smooth muscle hyperplasia Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域 technical field
本发明涉及一种金属材料,特别涉及一种表面改性的钛或钛合金材料,还涉及该表面改性的钛或钛合金材料的制备方法和应用。The invention relates to a metal material, in particular to a surface-modified titanium or titanium alloy material, and to a preparation method and application of the surface-modified titanium or titanium alloy material.
背景技术 Background technique
目前,由创伤、骨折及骨质疏松症等疾病引起的骨缺损是临床面临的普遍问题,每年全球有数以百万计的硬组织植入体用于骨固定或功能性组织全置换。钛及钛合金因其优良的生物相容性和综合力学性能成为目前临床应用最广泛的硬组织植入材料,用于制作人工关节、骨内固定器材及骨重建材料等。但是,钛及钛合金材料本身缺乏生物活性,无诱导骨整合性能,用其制成的植入体植入体内后不能与周围骨组织形成牢固的、长期稳定的结合,常发生松动和脱位现象。因此,钛及钛合金植入体与骨组织间的整合性及长期稳定性是目前临床面临的重大挑战。理想的骨组织植入体应具有“主动”而非“被动”地与宿主周边组织作用的能力,如促进成骨细胞的增殖和分化等。At present, bone defects caused by trauma, fractures, osteoporosis and other diseases are common clinical problems. Every year, millions of hard tissue implants are used for bone fixation or functional tissue replacement around the world. Due to their excellent biocompatibility and comprehensive mechanical properties, titanium and titanium alloys have become the most widely used hard tissue implant materials in clinical practice, and are used to make artificial joints, internal fixation devices and bone reconstruction materials. However, titanium and titanium alloy materials themselves lack biological activity and have no ability to induce osseointegration. Implants made of them cannot form a firm and long-term stable combination with surrounding bone tissue after implantation, and loosening and dislocation often occur . Therefore, the integration and long-term stability between titanium and titanium alloy implants and bone tissue are major clinical challenges. An ideal bone tissue implant should have the ability to "actively" rather than "passively" interact with the surrounding tissues of the host, such as promoting the proliferation and differentiation of osteoblasts.
针对钛及钛合金材料存在的不足,采用表面工程的方法对其进行表面改性,有望大幅度提高其综合性能,从而更适合于医学应用的要求。近年来,国内外学者就钛及钛合金材料的表面改性开展了大量的工作,其总体思路是在钛及钛合金表面生成有机(如蛋白质、酶等)或无机(如羟基磷灰石、二氧化钛等)生物活性涂层。表面改性方法大致分为三大类:物理改性法、化学改性法以及生物化学方法。物理改性法如等离子喷涂法等生产成本高,制得的羟基磷灰石涂层与钛及钛合金材料之间为物理结合,存在结合力较弱、稳定性较差的缺点,且绝大部分喷涂为直线喷涂,对复杂形貌的钛及钛合金材料容易造成涂层厚度不均匀等问题。化学改性法如酸碱处理法等对钛及钛合金材料的腐蚀性大,而且制得的二氧化钛涂层结构疏松,结合牢固性有待提高。生物化学方法是将蛋白质或酶等有机高分子物质通过物理吸附、化学键合以及载体附着等方法结合到钛及钛合金材料表面,其优势在于能够直接、有效地提高钛及钛合金材料的生物活性,但在如何保证反应后蛋白质或酶等的生物活性方面还需要进行大量的研究。迄今为止,还没有一种表面改性的钛及钛合金材料成功应用于临床。In view of the shortcomings of titanium and titanium alloy materials, surface modification by surface engineering methods is expected to greatly improve their comprehensive performance, so that they are more suitable for medical applications. In recent years, scholars at home and abroad have carried out a lot of work on the surface modification of titanium and titanium alloy materials. The general idea is to generate organic (such as protein, enzyme, etc.) or inorganic (such as hydroxyapatite, Titanium dioxide, etc.) bioactive coatings. Surface modification methods are roughly divided into three categories: physical modification methods, chemical modification methods, and biochemical methods. Physical modification methods such as plasma spraying methods have high production costs, and the prepared hydroxyapatite coating is physically bonded to titanium and titanium alloy materials, which has the disadvantages of weak bonding force and poor stability, and most Part of the spraying is linear spraying, which is easy to cause problems such as uneven coating thickness for titanium and titanium alloy materials with complex shapes. Chemical modification methods such as acid-base treatment are highly corrosive to titanium and titanium alloy materials, and the obtained titanium dioxide coating has a loose structure, and the bonding firmness needs to be improved. The biochemical method is to bind organic polymer substances such as proteins or enzymes to the surface of titanium and titanium alloy materials through physical adsorption, chemical bonding and carrier attachment. Its advantage is that it can directly and effectively improve the biological activity of titanium and titanium alloy materials. , but a lot of research is needed on how to ensure the biological activity of the protein or enzyme after the reaction. So far, no surface-modified titanium and titanium alloy materials have been successfully applied clinically.
发明内容 Contents of the invention
有鉴于此,为克服现有技术的不足,本发明的目的之一在于提供一种表面改性的钛或钛合金材料,具有良好的成骨细胞相容性,可促进成骨细胞的增殖和分化。In view of this, in order to overcome the deficiencies in the prior art, one of the purposes of the present invention is to provide a surface-modified titanium or titanium alloy material, which has good osteoblast compatibility and can promote the proliferation and differentiation.
为达到此目的,本发明的表面改性的钛或钛合金材料,在钛或钛合金材料的表面具有生物活性涂层,所述生物活性涂层由至少5层的壳聚糖-丝素蛋白双层组成。To achieve this purpose, the surface-modified titanium or titanium alloy material of the present invention has a bioactive coating on the surface of the titanium or titanium alloy material, and the bioactive coating consists of at least 5 layers of chitosan-silk fibroin Composed of two layers.
进一步,所述生物活性涂层由5~10层的壳聚糖-丝素蛋白双层组成;Further, the bioactive coating is composed of 5 to 10 layers of chitosan-silk fibroin bilayers;
进一步,所述生物活性涂层由6层的壳聚糖-丝素蛋白双层组成。Further, the bioactive coating is composed of 6 layers of chitosan-silk fibroin bilayers.
本发明的目的之二在于提供一种制备所述表面改性的钛或钛合金材料的方法,不受材料大小和形状的影响,操作简单,条件温和,无需特殊设备,生产成本低。The second object of the present invention is to provide a method for preparing the surface-modified titanium or titanium alloy material, which is not affected by the size and shape of the material, has simple operation, mild conditions, no need for special equipment, and low production cost.
为达到此目的,本发明的制备所述表面改性的钛或钛合金材料的方法,包括以下步骤:To achieve this purpose, the method for preparing the surface-modified titanium or titanium alloy material of the present invention comprises the following steps:
a、称取壳聚糖,加入浓度为10~30mL/L的乙酸溶液,搅拌使溶解,制成质量百分浓度为1%~4%的壳聚糖溶液;a, take chitosan, add the acetic acid solution that concentration is 10~30mL/L, stir to dissolve, make the chitosan solution that mass percent concentration is 1%~4%;
b、称取丝素蛋白,加入去离子水使溶解,制成质量百分浓度为2%~10%的丝素蛋白溶液;b. Weigh the silk fibroin, add deionized water to dissolve it, and make a silk fibroin solution with a concentration of 2% to 10% by mass;
c、称取1-乙基-3-(3-二甲胺基丙基)碳二亚胺盐酸盐(EDC)和吗啉乙磺酸(MES),加入去离子水使溶解,制成含有质量百分浓度为0.05%~2%的EDC和浓度为0.05~0.3mol/L的MES的混合溶液;c. Weigh 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and morpholineethanesulfonic acid (MES), add deionized water to dissolve, and make A mixed solution containing EDC with a concentration of 0.05% to 2% by mass and MES with a concentration of 0.05 to 0.3mol/L;
d、将钛或钛合金材料置步骤a制得的壳聚糖溶液中,浸泡10~20分钟,取出;d, put the titanium or titanium alloy material in the chitosan solution prepared in step a, soak for 10-20 minutes, and take it out;
e、将经过步骤d处理的钛或钛合金材料用去离子水充分洗涤;e. Fully washing the titanium or titanium alloy material treated in step d with deionized water;
f、将经过步骤e清洗的钛或钛合金材料置步骤b制得的丝素蛋白溶液中,浸泡10~20分钟,取出;f. Put the titanium or titanium alloy material cleaned in step e into the silk fibroin solution prepared in step b, soak for 10-20 minutes, and take it out;
g、将经过步骤f处理的钛或钛合金材料用去离子水充分洗涤;g, fully washing the titanium or titanium alloy material treated in step f with deionized water;
h、重复步骤d至g至少4次,使钛或钛合金材料的表面逐层自组装上至少5层的壳聚糖-丝素蛋白双层;h, repeat steps d to g at least 4 times, make the chitosan-silk fibroin bilayer of at least 5 layers self-assembled on the surface of titanium or titanium alloy material layer by layer;
i、将经过步骤h处理的钛或钛合金材料置步骤c制得的EDC-MES混合溶液中,在温度4~20℃条件下反应20~60分钟,即制得表面改性的钛或钛合金材料。i. Put the titanium or titanium alloy material treated in step h into the EDC-MES mixed solution prepared in step c, and react at a temperature of 4-20°C for 20-60 minutes to obtain surface-modified titanium or titanium Alloy materials.
进一步,所述步骤a中壳聚糖溶液的质量百分浓度为2%,所述步骤d中浸泡时间为20分钟;Further, the mass percent concentration of the chitosan solution in the step a is 2%, and the soaking time in the step d is 20 minutes;
进一步,所述步骤b中丝素蛋白溶液的质量百分浓度为5%,所述步骤f中浸泡时间为10分钟;Further, the mass percent concentration of the silk fibroin solution in the step b is 5%, and the soaking time in the step f is 10 minutes;
进一步,所述步骤c中混合溶液含有质量百分浓度为0.1%的EDC和浓度为0.1mol/L的MES,所述步骤i中反应温度为4℃、反应时间为30分钟。Further, the mixed solution in step c contains EDC with a concentration of 0.1% by mass and MES with a concentration of 0.1 mol/L, and the reaction temperature in step i is 4° C. and the reaction time is 30 minutes.
进一步,所述步骤h为重复步骤d至g4~9次,使钛或钛合金材料的表面逐层自组装上5~10层的壳聚糖-丝素蛋白双层;Further, the step h is to repeat steps d to
进一步,所述步骤h为重复步骤d至g5次,使钛或钛合金材料的表面逐层自组装上6层的壳聚糖-丝素蛋白双层。Further, the step h is to repeat steps d to
本发明的目的之三在于提供所述表面改性的钛或钛合金材料在制备医用硬组织植入材料中的应用。The third object of the present invention is to provide the application of the surface-modified titanium or titanium alloy material in the preparation of medical hard tissue implant materials.
本发明的有益效果在于:本发明公开了一种表面改性的钛或钛合金材料,在材料表面具有由至少5层的壳聚糖-丝素蛋白双层组成的生物活性涂层,该材料具有良好的成骨细胞相容性,可促进成骨细胞的增殖和分化,显示了进一步开发成为新型医用硬组织植入材料的潜力,具有良好的临床应用前景;本发明的表面改性的钛或钛合金材料可采用逐层自组装方法进行制备,通过静电吸附作用将聚阳离子电解质壳聚糖和聚阴离子电解质丝素蛋白交替层叠组装在钛或钛合金材料的表面,制备方法简单,涂层厚度可控,不受材料大小和形状的影响,适用于复杂形貌的材料,且制备条件温和,无需特殊设备,生产成本低,实用性强,具有较好的推广应用价值。The beneficial effects of the present invention are: the present invention discloses a surface-modified titanium or titanium alloy material, which has a bioactive coating consisting of at least five layers of chitosan-silk fibroin double layers on the surface of the material. It has good osteoblast compatibility, can promote the proliferation and differentiation of osteoblasts, and has shown the potential to be further developed into a new type of medical hard tissue implant material, and has good clinical application prospects; the surface-modified titanium of the present invention Or titanium alloy materials can be prepared by layer-by-layer self-assembly method, and polycationic electrolyte chitosan and polyanionic electrolyte silk fibroin are alternately stacked and assembled on the surface of titanium or titanium alloy materials through electrostatic adsorption. The preparation method is simple and the coating The thickness is controllable, not affected by the size and shape of the material, suitable for materials with complex shapes, and the preparation conditions are mild, no special equipment is required, the production cost is low, the practicability is strong, and it has good promotion and application value.
附图说明 Description of drawings
为了使本发明的目的、技术方案和优点更加清楚,下面将结合附图对本发明作进一步的详细描述,其中:In order to make the purpose, technical solutions and advantages of the present invention clearer, the present invention will be described in further detail below in conjunction with the accompanying drawings, wherein:
图1为成骨细胞在本发明的表面改性的钛膜上随时间的增殖示意图;Fig. 1 is a schematic diagram of the proliferation of osteoblasts over time on the surface-modified titanium film of the present invention;
图2为成骨细胞在本发明的表面改性的钛膜上随时间的分化示意图。Figure 2 is a schematic diagram of the differentiation of osteoblasts over time on the surface-modified titanium membrane of the present invention.
具体实施方式 Detailed ways
壳聚糖为甲壳类动物、昆虫和其它无脊椎动物外壳中的甲壳素脱乙酰化后的产物,是一种天然聚阳离子多糖(pKa=6.3),具有良好的成膜性、生物相容性、生物可降解性,以及多种生物活性如广谱抑菌、促进上皮细胞增长、抑制平滑肌增生等,广泛应用于组织工程、药物释放等领域。丝素蛋白是一种源于蚕丝的天然高分子蛋白质(pI=4.22),含有18种氨基酸,其中11种为人体必需氨基酸,具有优良的生物相容性和力学性能,可以缓慢降解,近年来,随着对其独特氨基酸组成及结晶结构等理化特性研究的深入,丝素蛋白在生物医学材料领域的应用日趋广泛和深入。本发明选择壳聚糖和丝素蛋白分别作为聚阳离子和聚阴离子电解质,利用聚阳/阴离子间的静电相互作用,采用逐层自组装的方法进行钛或钛合金材料的表面改性,并对制得的表面改性的钛或钛合金材料进行了生物活性鉴定。Chitosan is a product of deacetylation of chitin in the shell of crustaceans, insects and other invertebrates. It is a natural polycation polysaccharide (pKa=6.3) with good film-forming properties and biocompatibility. , biodegradability, and a variety of biological activities such as broad-spectrum antibacterial, promoting epithelial cell growth, inhibiting smooth muscle hyperplasia, etc., are widely used in tissue engineering, drug release and other fields. Silk fibroin is a natural high-molecular protein derived from silk (pI=4.22). It contains 18 kinds of amino acids, 11 of which are essential amino acids for human body. It has excellent biocompatibility and mechanical properties and can be slowly degraded. , with the in-depth study of its unique amino acid composition and crystal structure and other physical and chemical properties, the application of silk fibroin in the field of biomedical materials is becoming more and more extensive and in-depth. The present invention selects chitosan and silk fibroin as polycation and polyanion electrolyte respectively, utilizes the electrostatic interaction between polycation/anion, adopts the method for layer-by-layer self-assembly to carry out the surface modification of titanium or titanium alloy material, and to The prepared surface-modified titanium or titanium alloy materials were identified for biological activity.
以下将参照附图,对本发明的优选实施例进行详细的描述。Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.
原料:壳聚糖(脱乙酰度95%,分子量20万,青岛海汇生物制品有限公司);平整钛膜(通过电子束蒸发沉积,表面粗糙度约2.5nm)和Ti-6Al-4V钛合金(西北有色金属研究院);丝素蛋白自制,制备方法如下:称取天然蚕丝,在温度100℃条件下,用浓度为5mL/L的碳酸氢钠溶液脱胶2次,每次30分钟,用去离子水充分洗涤后,加入摩尔比为1∶2∶8的氯化钙-乙醇-水混合溶液,在温度70℃条件下搅拌6小时使溶解,再用去离子水透析3天,冷冻干燥,制得丝素蛋白。Raw materials: chitosan (deacetylation degree 95%, molecular weight 200,000, Qingdao Haihui Biological Products Co., Ltd.); flat titanium film (deposited by electron beam evaporation, surface roughness about 2.5nm) and Ti-6Al-4V titanium alloy (Northwest Institute of Nonferrous Metals); silk fibroin is self-made, and the preparation method is as follows: take natural silk by weighing, under the condition of temperature 100 ℃, degumming 2 times with the sodium bicarbonate solution that concentration is 5mL/L, every time 30 minutes, use After fully washing with deionized water, add calcium chloride-ethanol-water mixed solution with a molar ratio of 1:2:8, stir for 6 hours at a temperature of 70°C to dissolve, then dialyze with deionized water for 3 days, freeze-dry , to produce silk fibroin.
实施例一Embodiment one
本实施例为表面改性的钛膜,其制备方法包括以下步骤:This embodiment is a surface-modified titanium film, and its preparation method comprises the following steps:
a、称取壳聚糖0.5g,加入浓度为10mL/L的乙酸溶液50mL,磁力搅拌20分钟使溶解,制成质量百分浓度为1%的壳聚糖溶液;A, take by weighing chitosan 0.5g, adding concentration is 50mL of acetic acid solution of 10mL/L, magnetic stirring makes dissolving for 20 minutes, makes the chitosan solution that mass percent concentration is 1%;
b、称取丝素蛋白1.0g,加入去离子水50mL使溶解,制成质量百分浓度为2%的丝素蛋白溶液;b. Weigh 1.0 g of silk fibroin, add 50 mL of deionized water to dissolve it, and make a silk fibroin solution with a concentration of 2% by mass;
c、称取EDC 0.025g和MES 0.533g,加入去离子水50mL使溶解,制成含有质量百分浓度为0.05%的EDC和浓度为0.05mol/L的MES的混合溶液;c. Weigh 0.025g of EDC and 0.533g of MES, add 50mL of deionized water to dissolve, and make a mixed solution containing EDC with a concentration of 0.05% by mass and MES with a concentration of 0.05mol/L;
d、将钛膜置步骤a制得的壳聚糖溶液中,浸泡10分钟,取出;d, the titanium film is placed in the chitosan solution prepared in step a, soaked for 10 minutes, and taken out;
e、将经过步骤d处理的钛膜用去离子水清洗2次,每次浸泡2分钟;e. Washing the titanium membrane processed in step d twice with deionized water, soaking for 2 minutes each time;
f、将经过步骤e清洗的钛膜置步骤b制得的丝素蛋白溶液中,浸泡20分钟,取出;f. Put the titanium film cleaned in step e into the silk fibroin solution prepared in step b, soak for 20 minutes, and take it out;
g、将经过步骤f处理的钛膜用去离子水清洗2次,每次浸泡2分钟;g, cleaning the titanium film processed by step f with deionized water twice, soaking for 2 minutes each time;
h、重复步骤d至g4次,使钛膜表面逐层自组装上5层的壳聚糖-丝素蛋白双层;h, repeat steps d to g4 times, make the chitosan-silk fibroin bilayer of 5 layers on the surface of titanium film self-assembled layer by layer;
i、将经过步骤h处理的钛膜置步骤c制得的EDC-MES混合溶液中,在温度10℃条件下反应60分钟,即制得表面改性的钛膜。i. Put the titanium film treated in step h into the EDC-MES mixed solution prepared in step c, and react at a temperature of 10° C. for 60 minutes to prepare a surface-modified titanium film.
实施例二Embodiment two
本实施例为表面改性的钛膜,其制备方法包括以下步骤:This embodiment is a surface-modified titanium film, and its preparation method comprises the following steps:
a、称取壳聚糖1.0g,加入浓度为10mL/L的乙酸溶液50mL,磁力搅拌20分钟使溶解,制成质量百分浓度为2%的壳聚糖溶液;A, take chitosan 1.0g, add concentration and be 50mL of acetic acid solution of 10mL/L, magnetic stirring makes dissolving for 20 minutes, makes the chitosan solution that mass percent concentration is 2%;
b、称取丝素蛋白2.5g,加入去离子水50mL使溶解,制成质量百分浓度为5%的丝素蛋白溶液;b. Weigh 2.5 g of silk fibroin, add 50 mL of deionized water to dissolve, and make a silk fibroin solution with a concentration of 5% by mass;
c、称取EDC 0.050g和MES 1.066g,加入去离子水50mL使溶解,制成含有质量百分浓度为0.1%的EDC和浓度为0.1mol/L的MES的混合溶液;c. Weigh 0.050g of EDC and 1.066g of MES, add 50mL of deionized water to dissolve, and make a mixed solution containing EDC with a mass percentage concentration of 0.1% and MES with a concentration of 0.1mol/L;
d、将钛膜置步骤a制得的壳聚糖溶液中,浸泡20分钟,取出;d, the titanium film is placed in the chitosan solution prepared in step a, soaked for 20 minutes, and taken out;
e、将经过步骤d处理的钛膜用去离子水清洗3次,每次浸泡1分钟;e. Washing the titanium film treated in step d with deionized water 3 times, soaking for 1 minute each time;
f、将经过步骤e清洗的钛膜置步骤b制得的丝素蛋白溶液中,浸泡10分钟,取出;f. Put the titanium film cleaned in step e into the silk fibroin solution prepared in step b, soak for 10 minutes, and take it out;
g、将经过步骤f处理的钛膜用去离子水清洗3次,每次浸泡1分钟;g, cleaning the titanium film processed by step f with deionized water 3 times, soaking for 1 minute each time;
h、重复步骤c至f5次,使钛膜表面逐层自组装上6层的壳聚糖-丝素蛋白双层;h, repeat step c to f5 times, make the chitosan-silk fibroin bilayer of 6 layers on the surface of titanium film self-assembled layer by layer;
i、将经过步骤h处理的钛膜置步骤c制得的EDC-MES混合溶液中,在温度4℃条件下反应30分钟,即制得表面改性的钛膜。i. Put the titanium film treated in step h into the EDC-MES mixed solution prepared in step c, and react at a temperature of 4°C for 30 minutes to prepare a surface-modified titanium film.
实施例三Embodiment Three
本实施例为表面改性的Ti-6Al-4V钛合金,其制备方法包括以下步骤:Present embodiment is the Ti-6Al-4V titanium alloy of surface modification, and its preparation method comprises the following steps:
a、称取壳聚糖1.5g,加入浓度为20mL/L的乙酸溶液50mL,磁力搅拌20分钟使溶解,制成质量百分浓度为3%的壳聚糖溶液;A, take chitosan 1.5g, add concentration and be 50mL of the acetic acid solution of 20mL/L, magnetic stirring makes dissolving for 20 minutes, makes the chitosan solution that mass percent concentration is 3%;
b、称取丝素蛋白4.0g,加入去离子水50mL使溶解,制成质量百分浓度为8%的丝素蛋白溶液;b. Weigh 4.0 g of silk fibroin, add 50 mL of deionized water to dissolve it, and make a silk fibroin solution with a concentration of 8% by mass;
c、称取EDC 0.075g和MES 2.133g,加入去离子水50mL使溶解,制成含有质量百分浓度为0.15%的EDC和浓度为0.2mol/L的MES的混合溶液;c. Weigh 0.075g of EDC and 2.133g of MES, add 50mL of deionized water to dissolve, and make a mixed solution containing EDC with a mass percentage concentration of 0.15% and MES with a concentration of 0.2mol/L;
d、将钛合金置步骤a制得的壳聚糖溶液中,浸泡15分钟,取出;d, put titanium alloy in the chitosan solution that step a makes, soak for 15 minutes, take out;
e、将经过步骤d处理的钛合金用去离子水清洗3次,每次浸泡1分钟;e, cleaning the titanium alloy processed by step d with deionized water 3 times, soaking for 1 minute each time;
f、将经过步骤e清洗的钛合金置步骤b制得的丝素蛋白溶液中,浸泡15分钟,取出;f. Put the titanium alloy cleaned in step e into the silk fibroin solution prepared in step b, soak for 15 minutes, and take it out;
g、将经过步骤f处理的钛合金用去离子水清洗3次,每次浸泡1分钟;g, cleaning the titanium alloy processed through step f with deionized water 3 times, soaking for 1 minute each time;
h、重复步骤c至f7次,使钛膜表面逐层自组装上8层的壳聚糖-丝素蛋白双层;h, repeat steps c to f7 times, make the chitosan-silk fibroin bilayer of 8 layers self-assembled layer by layer on the titanium film surface;
i、将经过步骤h处理的钛膜置步骤c制得的EDC-MES混合溶液中,在温度15℃条件下反应45分钟,即制得表面改性的钛膜。i. Put the titanium film treated in step h into the EDC-MES mixed solution prepared in step c, and react at a temperature of 15° C. for 45 minutes to prepare a surface-modified titanium film.
实施例四Embodiment four
本实施例为表面改性的Ti-6Al-4V钛合金,其制备方法包括以下步骤:Present embodiment is the Ti-6Al-4V titanium alloy of surface modification, and its preparation method comprises the following steps:
a、称取壳聚糖2.0g,加入浓度为30mL/L的乙酸溶液50mL,磁力搅拌20分钟使溶解,制成质量百分浓度为4%的壳聚糖溶液;A, take chitosan 2.0g, add concentration and be 50mL of acetic acid solution of 30mL/L, magnetic stirring makes dissolving for 20 minutes, makes the chitosan solution that mass percent concentration is 4%;
b、称取丝素蛋白5.0g,加入去离子水50mL使溶解,制成质量百分浓度为10%的丝素蛋白溶液;b. Weigh 5.0 g of silk fibroin, add 50 mL of deionized water to dissolve, and make a silk fibroin solution with a concentration of 10% by mass;
c、称取EDC 0.100g和MES 3.199g,加入去离子水50mL使溶解,制成含有质量百分浓度为0.2%的EDC和浓度为0.3mol/L的MES的混合溶液;c. Weigh 0.100g of EDC and 3.199g of MES, add 50mL of deionized water to dissolve, and make a mixed solution containing EDC with a concentration of 0.2% by mass and MES with a concentration of 0.3mol/L;
d、将钛膜置步骤a制得的壳聚糖溶液中,浸泡20分钟,取出;d, the titanium film is placed in the chitosan solution prepared in step a, soaked for 20 minutes, and taken out;
e、将经过步骤d处理的钛膜用去离子水清洗4次,每次浸泡1分钟;e. Washing the titanium film treated in step d with
f、将经过步骤e清洗的钛膜置步骤b制得的丝素蛋白溶液中,浸泡20分钟,取出;f. Put the titanium film cleaned in step e into the silk fibroin solution prepared in step b, soak for 20 minutes, and take it out;
g、将经过步骤f处理的钛膜用去离子水清洗4次,每次浸泡1分钟;g. Washing the titanium film processed by step f with
h、重复步骤c至f9次,使钛膜表面逐层自组装上10层的壳聚糖-丝素蛋白双层;h, repeat steps c to f9 times, make the chitosan-silk fibroin bilayer of 10 layers self-assembled layer by layer on the titanium film surface;
i、将经过步骤h处理的钛膜置步骤c制得的EDC-MES混合溶液中,在温度20℃条件下反应20分钟,即制得表面改性的钛膜。i. Put the titanium film treated in step h into the EDC-MES mixed solution prepared in step c, and react at a temperature of 20° C. for 20 minutes to prepare a surface-modified titanium film.
本发明的表面改性的钛或钛合金材料的生物活性鉴定Bioactivity identification of the surface-modified titanium or titanium alloy material of the present invention
1、成骨细胞的增殖能力鉴定1. Identification of proliferation ability of osteoblasts
方法:将小鼠颅骨原代成骨细胞分别接种于未改性的钛膜表面、本发明的表面改性的钛膜表面和聚苯乙烯细胞培养孔板(tissue culture polystyrenes,TCPS)内,细胞密度为5000/cm2,用含有浓度为100mL/L的胎牛血清的DMEM培养液,在温度37℃、CO2气体浓度为50mL/m3的条件下培养,每3天更换培养液;分别于培养第1、4、7天,将细胞用浓度为2.5mg/mL的胰酶溶液消化后,用Z1型库尔特计数器(Coulter Counter,德国Beckman Coulter GmbH公司)进行细胞计数,检测细胞增殖能力;Method: Mouse calvarial primary osteoblasts were inoculated on the surface of unmodified titanium membrane, the surface of the surface-modified titanium membrane of the present invention and polystyrene cell culture well plates (tissue culture polystyrenes, TCPS). Density is 5000/cm 2 , with DMEM culture solution containing fetal bovine serum at a concentration of 100mL/L, cultured at a temperature of 37°C and a CO 2 gas concentration of 50mL/m 3 , and the culture solution is replaced every 3 days; On the 1st, 4th, and 7th day of culture, the cells were digested with a trypsin solution with a concentration of 2.5 mg/mL, and the cells were counted with a Z1-type Coulter Counter (Beckman Coulter GmbH, Germany) to detect cell proliferation. ability;
结果:如图1所示,与未改性的钛膜和TCPS相比,本发明的表面改性的钛膜具有良好的成骨细胞相容性,可促进成骨细胞的增殖。Results: As shown in Figure 1, compared with the unmodified titanium film and TCPS, the surface-modified titanium film of the present invention has good osteoblast compatibility and can promote the proliferation of osteoblasts.
2、成骨细胞的分化能力鉴定2. Identification of osteoblast differentiation ability
方法:将小鼠颅骨原代成骨细胞分别接种于未改性的钛膜表面、本发明的表面改性的钛膜表面和TCPS内,细胞密度为5000/cm2,用含有浓度为100mL/L的胎牛血清的DMEM培养液,在温度37℃、CO2气体浓度为50mL/m3的条件下培养,每3天更换培养液;于培养第7天,将细胞用浓度为2.5mg/mL的胰酶溶液消化后,离心,细胞沉淀中加入浓度为10mL/L的曲拉通X-100(Triton X-100)溶液,重复“冷冻-室温融化”共3次,制得细胞裂解液,先用BCA蛋白定量试剂盒(美国Sigma公司)测定细胞蛋白含量,再加入底物硝基苯磷酸盐反应,用微板计数器在波长450nm处测定硝基酚的合成情况,以每毫克蛋白每分钟合成硝基酚的微摩尔数“μmol硝基酚/分钟/mg蛋白”表征碱性磷酸酶(ALP)的活性,检测细胞分化能力;Method: Primary osteoblasts from the mouse skull were inoculated on the surface of the unmodified titanium membrane, the surface of the surface-modified titanium membrane of the present invention and in TCPS respectively, the cell density was 5000/cm 2 , and the concentration was 100mL/ The DMEM culture fluid of L fetal bovine serum was cultivated under the conditions of temperature 37°C and CO 2 gas concentration of 50mL/m 3 , and the culture fluid was changed every 3 days; After digesting mL of trypsin solution, centrifuge, add Triton X-100 (Triton X-100) solution with a concentration of 10mL/L to the cell pellet, and repeat "freezing-room temperature thawing" for a total of 3 times to obtain a cell lysate First, use the BCA protein quantification kit (Sigma Company, U.S.) to measure the protein content of cells, then add the substrate nitrophenylphosphate to react, and use a microplate counter to measure the synthesis of nitrophenol at a wavelength of 450nm. The number of micromoles of nitrophenol synthesized in minutes "μmol nitrophenol/min/mg protein" indicates the activity of alkaline phosphatase (ALP) and detects the ability of cell differentiation;
结果:如图2所示,与未改性的钛膜和TCPS相比,本发明的表面改性的钛膜具有良好的成骨细胞相容性,可促进成骨细胞的分化。Results: As shown in Figure 2, compared with the unmodified titanium membrane and TCPS, the surface-modified titanium membrane of the present invention has good osteoblast compatibility and can promote the differentiation of osteoblasts.
最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管通过参照本发明的优选实施例已经对本发明进行了描述,但本领域的普通技术人员应当理解,可以在形式上和细节上对其作出各种各样的改变,而不偏离所附权利要求书所限定的本发明的精神和范围。Finally, it is noted that the above embodiments are only used to illustrate the technical solutions of the present invention and not to limit them. Although the present invention has been described with reference to the preferred embodiments of the present invention, those skilled in the art should understand that it can be described in the form Various changes may be made in matter and details thereof without departing from the spirit and scope of the invention as defined in the appended claims.
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008102330814A CN101411893A (en) | 2008-11-20 | 2008-11-20 | Titanium or titanium alloy material with modified surface as well as preparation method and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008102330814A CN101411893A (en) | 2008-11-20 | 2008-11-20 | Titanium or titanium alloy material with modified surface as well as preparation method and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101411893A true CN101411893A (en) | 2009-04-22 |
Family
ID=40592767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008102330814A Pending CN101411893A (en) | 2008-11-20 | 2008-11-20 | Titanium or titanium alloy material with modified surface as well as preparation method and use thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101411893A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102058904A (en) * | 2010-12-31 | 2011-05-18 | 重庆大学 | Biological functionalized nano titanium material and preparation method thereof |
CN102094227A (en) * | 2011-01-07 | 2011-06-15 | 武汉大学 | Electrochemical method for preparing chitosan/silk fibroin composite coating on surface of titanium implant |
CN101745150B (en) * | 2009-12-31 | 2013-02-27 | 重庆大学 | Gene activated titanium material and preparation method thereof |
US9433698B2 (en) | 2010-08-30 | 2016-09-06 | President And Fellows Of Harvard College | High strength chitin composite material and method of making |
CN106237376A (en) * | 2016-03-28 | 2016-12-21 | 上海交通大学医学院附属第九人民医院 | Titanio biomaterial for medical purpose that chitosan quaternary ammonium salt group compound film is modified and preparation method thereof |
CN106512082A (en) * | 2016-11-28 | 2017-03-22 | 哈尔滨医科大学 | Composite structure capable of retarding magnesium-alloy degradation under coating by silk fibroin |
CN107693843A (en) * | 2017-04-01 | 2018-02-16 | 华东理工大学 | The surface modifying method of biomedical active titanium and its alloy implantation material |
-
2008
- 2008-11-20 CN CNA2008102330814A patent/CN101411893A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745150B (en) * | 2009-12-31 | 2013-02-27 | 重庆大学 | Gene activated titanium material and preparation method thereof |
US9433698B2 (en) | 2010-08-30 | 2016-09-06 | President And Fellows Of Harvard College | High strength chitin composite material and method of making |
CN102058904A (en) * | 2010-12-31 | 2011-05-18 | 重庆大学 | Biological functionalized nano titanium material and preparation method thereof |
CN102094227A (en) * | 2011-01-07 | 2011-06-15 | 武汉大学 | Electrochemical method for preparing chitosan/silk fibroin composite coating on surface of titanium implant |
CN106237376A (en) * | 2016-03-28 | 2016-12-21 | 上海交通大学医学院附属第九人民医院 | Titanio biomaterial for medical purpose that chitosan quaternary ammonium salt group compound film is modified and preparation method thereof |
CN106237376B (en) * | 2016-03-28 | 2019-06-07 | 上海交通大学医学院附属第九人民医院 | The modified titanium-based biomaterial for medical purpose and preparation method thereof of chitosan quaternary ammonium salt group compound film |
CN106512082A (en) * | 2016-11-28 | 2017-03-22 | 哈尔滨医科大学 | Composite structure capable of retarding magnesium-alloy degradation under coating by silk fibroin |
CN106512082B (en) * | 2016-11-28 | 2019-03-26 | 哈尔滨医科大学 | A kind of composite construction that magnesium alloy can be delayed to degrade under fibroin albumen cladding |
CN107693843A (en) * | 2017-04-01 | 2018-02-16 | 华东理工大学 | The surface modifying method of biomedical active titanium and its alloy implantation material |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tao et al. | Osteoimmunomodulation mediating improved osteointegration by OGP-loaded cobalt-metal organic framework on titanium implants with antibacterial property | |
Jia et al. | Bioinspired anchoring AgNPs onto micro-nanoporous TiO2 orthopedic coatings: Trap-killing of bacteria, surface-regulated osteoblast functions and host responses | |
CN101411893A (en) | Titanium or titanium alloy material with modified surface as well as preparation method and use thereof | |
CN101411894B (en) | Self-assembly modified titanium or titanium alloy material from layer to layer as well as preparation method and use thereof | |
Wang et al. | Porous surface with fusion peptides embedded in strontium titanate nanotubes elevates osteogenic and antibacterial activity of additively manufactured titanium alloy | |
CN105688274B (en) | A kind of preparation process of polycaprolactone/gelatin electrospinning compound rest | |
Zhong et al. | Recent advances and trends in the applications of MXene nanomaterials for tissue engineering and regeneration | |
CN107661544B (en) | Antibacterial and osteopromoting composite functional porous orthopedic implant and preparation method thereof | |
CN103463675B (en) | Antibacterial and antitumor orthopaedic implantation material and preparation method thereof | |
Zhang et al. | Surface modification of Titanium implants by pH-Responsive coating designed for Self-Adaptive antibacterial and promoted osseointegration | |
Karaji et al. | A multifunctional silk coating on additively manufactured porous titanium to prevent implant-associated infection and stimulate bone regeneration | |
Nijhuis et al. | Wet‐chemical deposition of functional coatings for bone implantology | |
CN102560598B (en) | Method for preparing medical titanium material with high anti-cancer and antibacterial properties | |
CN104941002A (en) | Preparation method of bacterial responsive titanium-based antibacterial implantation material for hyaluronidase secreting type bacteria | |
EP4023264A1 (en) | Method for constructing bone morphogenetic protein sustained-release system | |
Yang et al. | Biomimetic design of double-sided functionalized silver nanoparticle/bacterial cellulose/hydroxyapatite hydrogel mesh for temporary cranioplasty | |
CN101905034A (en) | Preparation method of chitosan antibacterial biomaterial modified by biological polysaccharide self-assembly | |
CN107213529A (en) | A kind of preparation method for being used to improve the degradable medical polymer three-dimensional material of Gegenbaur's cell adhesion and bone formation performance | |
CN107693843A (en) | The surface modifying method of biomedical active titanium and its alloy implantation material | |
Fu et al. | Sericin/nano-hydroxyapatite hydrogels based on graphene oxide for effective bone regeneration via immunomodulation and osteoinduction | |
Du et al. | A multifunctional hybrid inorganic-organic coating fabricated on magnesium alloy surface with antiplatelet adhesion and antibacterial activities | |
Aghazadeh et al. | Recent advances in development of natural cellulosic non-woven scaffolds for tissue engineering | |
CN106729964A (en) | It is a kind of to have promoting bone growing concurrently and suppress titania nanotube of bone resorption and preparation method thereof | |
Wang et al. | Surface-activated 3D-printed PEEK implant enhances anti-infection and osteogenesis | |
Wang et al. | Zeolitic imidazolate framework-8 with encapsulated naringin synergistically improves antibacterial and osteogenic properties of Ti implants for osseointegration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20090422 |